144 related articles for article (PubMed ID: 14965807)
1. Immunosuppression induction with daclizumab and antithymocyte globulin in cardiac transplantation: clinical experience with 8 cases.
Huang XS; Chen DZ; Chen LW; Li ZQ; Liao CX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):126-8. PubMed ID: 14965807
[TBL] [Abstract][Full Text] [Related]
2. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
Beniaminovitz A; Itescu S; Lietz K; Donovan M; Burke EM; Groff BD; Edwards N; Mancini DM
N Engl J Med; 2000 Mar; 342(9):613-9. PubMed ID: 10699160
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
[TBL] [Abstract][Full Text] [Related]
4. Rabbit antithymocyte globulin. A 10-year experience in cardiac transplantation.
Copeland JG; Icenogle TB; Williams RJ; Rosado LJ; Butman SM; Vasu MA; Sethi GK; McDonald AN; Klees E; Rhenman MJ
J Thorac Cardiovasc Surg; 1990 May; 99(5):852-60. PubMed ID: 2329823
[TBL] [Abstract][Full Text] [Related]
5. Successful reversal of acute cardiac allograft rejection with OKT*3 monoclonal antibody.
Costanzo-Nordin MR; Silver MA; O'Connell JB; Pifarre R; Grady KL; Winters GL; Murdock DK; Sullivan HJ; Grieco JG; Scanlon PJ
Circulation; 1987 Nov; 76(5 Pt 2):V71-80. PubMed ID: 3311459
[TBL] [Abstract][Full Text] [Related]
6. Induction of immunosuppression with rabbit antithymocyte globulin: five-year experience in cardiac transplantation.
Carrier M; Pelletier GB; Cartier R; Leclerc Y; Robitaille D; Pelletier LC
Can J Cardiol; 1993 Mar; 9(2):171-6. PubMed ID: 8490788
[TBL] [Abstract][Full Text] [Related]
7. A comparison of daclizumab to ATGAM induction in simultaneous pancreas-kidney transplant recipients on triple maintenance immunosuppression.
Rasaiah SB; Light JA; Sasaki TM; Currier CB
Clin Transplant; 2000 Aug; 14(4 Pt 2):409-12. PubMed ID: 10946780
[TBL] [Abstract][Full Text] [Related]
8. Use of antilymphocyte induction therapy in liver transplantation.
Wall WJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S64-70. PubMed ID: 10431019
[TBL] [Abstract][Full Text] [Related]
9. Reversal of cardiac transplant rejection without massive immunosuppression.
Michler RE; Smith CR; Drusin RE; Reison DS; Hickey TJ; Lamb J; Reemtsma K; Rose EA
Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cardiac rejection in heart and heart-lung transplantation.
Baldwin JC; Oyer PE; Stinson EB; Starnes VA; Billingham ME; Shumway NE
J Heart Transplant; 1987; 6(6):352-6. PubMed ID: 3121819
[TBL] [Abstract][Full Text] [Related]
11. Rejection prophylaxis with murine monoclonal CD-3 antibody (OKT3): considerations for early hospital discharge.
Herrick CM; Mealey PC; Hagan ME; Holland CS; Volkman AK; Menlove RL
J Heart Transplant; 1989; 8(1):67-70. PubMed ID: 2647934
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression following cardiac transplantation.
Woodley SL; Renlund DG; O'Connell JB; Bristow MR
Cardiol Clin; 1990 Feb; 8(1):83-96. PubMed ID: 2407363
[TBL] [Abstract][Full Text] [Related]
13. Antithymocyte globulin or interleukin 2 receptor antibody for immunosuppressive induction therapy after orthotopic liver transplantation: a follow-up study.
Keck H; Langrehr JM; Knoop M; Lohmann R; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2701. PubMed ID: 8356721
[No Abstract] [Full Text] [Related]
14. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241
[No Abstract] [Full Text] [Related]
15. Strategies of immunosuppression in cardiac transplantation.
Renlund DG; O'Connell JB; Bristow MR
Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):181-8. PubMed ID: 2127901
[TBL] [Abstract][Full Text] [Related]
16. Heart transplantation--a two-year experience.
Hetzer R; Warnecke H; Schüler S; Süthoff U; Borst HG
Z Kardiol; 1985; 74 Suppl 6():51-8. PubMed ID: 3913180
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cardiac allograft rejection with intravenous corticosteroids.
Miller LW
J Heart Transplant; 1990; 9(3 Pt 2):283-7. PubMed ID: 2355284
[TBL] [Abstract][Full Text] [Related]
18. Monitoring immunosuppression following renal transplantation.
Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of malignant neoplasms in cardiac transplant recipients uniformly treated with prophylactic antilymphocyte globulin.
Dresdale AR; Lutz S; Drost C; Levine TB; Fenn N; Paone G; del Busto R; Silverman NA
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1202-7. PubMed ID: 8246561
[TBL] [Abstract][Full Text] [Related]
20. Induction immunosuppression with OKT3 monoclonal antibody in cardiac transplant recipients.
Pulpón LA; Domínguez P; Cháfer M; Segovia J; Crespo MG; Pradas G; Burgos R; Figuera D
Transplant Proc; 1990 Oct; 22(5):2319. PubMed ID: 2120816
[No Abstract] [Full Text] [Related]
[Next] [New Search]